Investopedia: BD Healthy But No Great Bargain

It stands to reason that in an industry still struggling with weak end-user demand, the companies that are executing well are not especially cheap. That could apply to Intuitive Surgical (Nasdaq:ISRG) or St. Jude (NYSE:STJ), and it certainly seems to be true of Becton Dickinson (or BD) (NYSE:BDX). This remains a fine company, one of the best in health care, but that quality is already largely in the stock price. (To learn more about this sector, check out Investing In The Health Care Sector.)

An On-Target Second Quarter  

BD didn't shock anybody with its second quarter earnings, but "good enough" is definitely good enough these days in health care. Overall reported revenue rose 10% from last year's level, while currency-adjusted revenue was up more on the order of 5%.

 

Read more at this link:
http://stocks.investopedia.com/stock-analysis/2011/BD-Healthy-But-No-Great-Bargain-BDX-JNJ-BCR-COV-BAX-HOLX-ABT-CPHD0808.aspx